Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Weaver JM, Sant AJ.

Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7. Review.

PMID:
19198764
2.

The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.

Sant AJ, Chaves FA, Jenks SA, Richards KA, Menges P, Weaver JM, Lazarski CA.

Immunol Rev. 2005 Oct;207:261-78. Review.

PMID:
16181342
3.
4.

The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.

Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ.

Immunity. 2005 Jul;23(1):29-40.

5.

Antigen-presenting cells and the selection of immunodominant epitopes.

Blum JS, Ma C, Kovats S.

Crit Rev Immunol. 1997;17(5-6):411-7. Review.

PMID:
9419428
6.

Exogenous antigens bind MHC class II first, and are processed by cathepsins later.

Sadegh-Nasseri S, Kim A.

Mol Immunol. 2015 Dec;68(2 Pt A):81-4. doi: 10.1016/j.molimm.2015.07.018. Epub 2015 Aug 5. Review.

7.

The ins and outs of MHC class II-mediated antigen processing and presentation.

Roche PA, Furuta K.

Nat Rev Immunol. 2015 Apr;15(4):203-16. doi: 10.1038/nri3818. Epub 2015 Feb 27. Review.

PMID:
25720354
8.

Direct observation of ligand recognition by T cells.

Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM.

Nature. 2002 Oct 24;419(6909):845-9.

PMID:
12397360
9.

An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Menges PR, Jenks SA, Bikoff EK, Friedmann DR, Knowlden ZA, Sant AJ.

J Immunol. 2008 Feb 1;180(3):1619-33.

10.

How HLA-DM works: recognition of MHC II conformational heterogeneity.

Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K.

Front Biosci (Schol Ed). 2012 Jun 1;4:1325-32. Review.

PMID:
22652874
11.
12.
14.

Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.

Zhou G, Ding ZC, Fu J, Levitsky HI.

J Immunol. 2011 Feb 15;186(4):2148-55. doi: 10.4049/jimmunol.1002917. Epub 2011 Jan 17.

15.

Role of APC in the selection of immunodominant T cell epitopes.

Ma C, Whiteley PE, Cameron PM, Freed DC, Pressey A, Chen SL, Garni-Wagner B, Fang C, Zaller DM, Wicker LS, Blum JS.

J Immunol. 1999 Dec 15;163(12):6413-23.

16.

Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.

Kremer AN, van der Meijden ED, Honders MW, Goeman JJ, Wiertz EJ, Falkenburg JH, Griffioen M.

Blood. 2012 Oct 18;120(16):3246-55. doi: 10.1182/blood-2011-12-399311. Epub 2012 Aug 13.

17.

Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.

Weaver JM, Lazarski CA, Richards KA, Chaves FA, Jenks SA, Menges PR, Sant AJ.

J Immunol. 2008 Sep 1;181(5):3039-48.

19.
20.

Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application.

Call MJ.

Mol Immunol. 2011 Sep;48(15-16):1735-43. doi: 10.1016/j.molimm.2011.05.022. Epub 2011 Jun 14. Review.

PMID:
21676462

Supplemental Content

Support Center